These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 17325714)

  • 1. No preferential transmission of paternal alleles at risk genes in attention-deficit hyperactivity disorder.
    Laurin N; Feng Y; Ickowicz A; Pathare T; Malone M; Tannock R; Schachar R; Kennedy JL; Barr CL
    Mol Psychiatry; 2007 Mar; 12(3):226-9. PubMed ID: 17325714
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine transporter haplotype and attention-deficit hyperactivity disorder.
    Galili-Weisstub E; Levy S; Frisch A; Gross-Tsur V; Michaelovsky E; Kosov A; Meltzer A; Goltser T; Serretti A; Cusin C; Darvasi A; Inbar E; Weizman A; Segman RH
    Mol Psychiatry; 2005 Jul; 10(7):617-8. PubMed ID: 15940306
    [No Abstract]   [Full Text] [Related]  

  • 3. What are the key directions in the genetics of attention deficit hyperactivity disorder?
    Martin N; McDougall M; Hay DA
    Curr Opin Psychiatry; 2008 Jul; 21(4):356-61. PubMed ID: 18520740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics of attention-deficit/hyperactivity disorder.
    Coghill D; Banaschewski T
    Expert Rev Neurother; 2009 Oct; 9(10):1547-65. PubMed ID: 19831843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental risk factors and attention-deficit/hyperactivity disorder symptoms.
    Freitag CM; Meyer J; Reif A; Rösler M; Lesch KP; Retz W
    Arch Gen Psychiatry; 2008 Mar; 65(3):356-7; author reply 357-8. PubMed ID: 18316682
    [No Abstract]   [Full Text] [Related]  

  • 6. Preferential transmission of paternal alleles at risk genes in attention-deficit/hyperactivity disorder.
    Hawi Z; Segurado R; Conroy J; Sheehan K; Lowe N; Kirley A; Shields D; Fitzgerald M; Gallagher L; Gill M
    Am J Hum Genet; 2005 Dec; 77(6):958-65. PubMed ID: 16380908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association between dopaminergic polymorphisms and intelligence variability in attention-deficit/hyperactivity disorder.
    Genro JP; Roman T; Zeni CP; Grevet EH; Schmitz M; de Abreu PB; Bau CH; Rohde LA; Hutz MH
    Mol Psychiatry; 2006 Dec; 11(12):1066-7. PubMed ID: 17130883
    [No Abstract]   [Full Text] [Related]  

  • 8. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample.
    Laucht M; Skowronek MH; Becker K; Schmidt MH; Esser G; Schulze TG; Rietschel M
    Arch Gen Psychiatry; 2007 May; 64(5):585-90. PubMed ID: 17485610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The early development of child psychopharmacogenetics.
    Cook EH
    J Am Acad Child Adolesc Psychiatry; 1999 Dec; 38(12):1478-81. PubMed ID: 10596246
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile].
    Henríquez B H; Henríquez H M; Carrasco Ch X; Rothhammer A P; Llop R E; Aboitiz F; Rothhammer E F
    Rev Med Chil; 2008 Jun; 136(6):719-24. PubMed ID: 18769827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).
    Oades RD
    Prog Brain Res; 2008; 172():543-65. PubMed ID: 18772050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of an association of a promoter polymorphism of the dopamine transporter gene and Attention Deficit Hyperactivity Disorder.
    Doyle C; Brookes K; Simpson J; Park J; Scott S; Coghill DR; Hawi Z; Kirley A; Gill M; Kent L
    Neurosci Lett; 2009 Sep; 462(2):179-81. PubMed ID: 19576958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review: Genetics of attention deficit/hyperactivity disorder.
    Wallis D; Russell HF; Muenke M
    J Pediatr Psychol; 2008; 33(10):1085-99. PubMed ID: 18522996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of dopamine transporter genotype with prenatal smoke exposure on ADHD symptoms.
    Becker K; El-Faddagh M; Schmidt MH; Esser G; Laucht M
    J Pediatr; 2008 Feb; 152(2):263-9. PubMed ID: 18206700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6-10 age.
    Kopecková M; Paclt I; Petrásek J; Pacltová D; Malíková M; Zagatová V
    Neuro Endocrinol Lett; 2008 Apr; 29(2):246-51. PubMed ID: 18404133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association and linkage of allelic variants of the dopamine transporter gene in ADHD.
    Friedel S; Saar K; Sauer S; Dempfle A; Walitza S; Renner T; Romanos M; Freitag C; Seitz C; Palmason H; Scherag A; Windemuth-Kieselbach C; Schimmelmann BG; Wewetzer C; Meyer J; Warnke A; Lesch KP; Reinhardt R; Herpertz-Dahlmann B; Linder M; Hinney A; Remschmidt H; Schäfer H; Konrad K; Hübner N; Hebebrand J
    Mol Psychiatry; 2007 Oct; 12(10):923-33. PubMed ID: 17579611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention-deficit/hyperactivity disorder: current aspects on pharmacogenetics.
    Rohde LA; Roman T; Hutz MH
    Pharmacogenomics J; 2003; 3(1):11-3. PubMed ID: 12629578
    [No Abstract]   [Full Text] [Related]  

  • 18. What do dopamine transporter and catechol-o-methyltransferase tell us about attention deficit-hyperactivity disorder? Pharmacogenomic implications.
    Levy F
    Aust N Z J Psychiatry; 2007 Jan; 41(1):10-6. PubMed ID: 17464676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder.
    Bellgrove MA; Johnson KA; Barry E; Mulligan A; Hawi Z; Gill M; Robertson I; Chambers CD
    Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gene for synapsin III and attention-deficit hyperactivity disorder.
    Makkar R; Gomez L; Wigg KG; Ickowicz A; Pathare T; Tannock R; Malone M; Kennedy JL; Schachar R; Barr CL
    Psychiatr Genet; 2007 Apr; 17(2):109-12. PubMed ID: 17413450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.